Recommendation ID
NICE recommended that clinical data, including genotype and sustained virological response at 12 weeks, are collected for all people having treatment with simeprevir in the NHS.
Any explanatory notes
(if applicable)
NICE heard from the NHS commissioning expert that NHS England is intending to collect clinical data from people having treatment with the new generation of hepatitis C virus treatments. NICE agreed that such efforts should be supported to enable use of clinical data collected in routine clinical practice in any review of guidance on these treatments.

Source guidance details

Comes from guidance
Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment
Date issued
February 2015

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 23/04/2015